<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge for $16,000.00 on July 12, 2017. Work is performed in Great Britain, United Kingdom. The purchase order supports the NIH Oxford-Cambridge Scholars Program, providing funding for advanced doctoral training. The order has an ultimate completion date of July 31, 2018 and is structured as a firm fixed-price purchase order.</p>
<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge valued at $16,000 on May 18, 2018, to support a new member of the NIH Oxford-Cambridge Scholars Program. Performance takes place in Great Britain, United Kingdom, with an ultimate completion date of May 31, 2019. The order is firm fixed price with no set-aside designation.</p>
<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge on May 18, 2018, valued at $16,000 for participation in the NIH Oxford-Cambridge Scholars Program. Performance takes place in Great Britain, United Kingdom, with an ultimate completion date of May 31, 2019. The order is firm fixed price with no set-aside classification.</p>
<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge for $16,000 on July 10, 2017. Work is performed in Great Britain, United Kingdom. The order supports the Oxford-Cambridge Scholars Program, providing educational and training services for NIH Fellows pursuing doctoral research in biomedical fields. The order has a firm fixed price structure and an ultimate completion date of July 31, 2018.</p>
<p>The National Institute of Allergy and Infectious Diseases issued a purchase order to The Chancellor, Masters, and Scholars of the University of Cambridge for $16,000.00 on July 7, 2017. The order supports the NIH Oxford-Cambridge Scholars Program, providing funding for new members enrolled in the doctoral partnership. Place of performance is Great Britain, United Kingdom. The order was completed by July 31, 2018.</p>
<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge valued at $16,000 on May 18, 2018. The order supports enrollment of Alex Waldman as a new member of the NIH Oxford-Cambridge Scholars Program. Performance occurs in Great Britain, United Kingdom, with an ultimate completion date of May 31, 2019. Pricing is firm fixed price.</p>
<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge for $16,000 on May 18, 2018. The order supports enrollment of John Shannon as a new member of the NIH Oxford-Cambridge Scholars Program. Performance occurs in Great Britain, United Kingdom. The purchase order is firm fixed price and runs through May 31, 2019.</p>
The National Institute of Allergy and Infectious Diseases issued a purchase order to the University of Cambridge on July 12, 2017, valued at $16,000 for participation in the NIH Oxford-Cambridge Scholars Program. Performance occurs in Great Britain, United Kingdom, with an ultimate completion date of July 31, 2018. The order supports advanced doctoral training under the Oxford-Cambridge University Doctoral Partnership program, providing tuition and fees for NIH Fellows pursuing doctoral research...
<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge valued at $16,000 on May 18, 2018. The order supports Matthew Mule's participation as a new member of the NIH Oxford-Cambridge Scholars Program, with an ultimate completion date of May 31, 2019. Performance takes place in Great Britain, United Kingdom. The contract is firm fixed price with no set-aside designation.</p>
<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to the University of Cambridge for $196,000.00 on April 23, 2018, to support continuing students in the Oxford-Cambridge University Doctoral Partnership Training Program. The order carries a firm fixed price structure with an ultimate completion date of September 30, 2018. Performance takes place in Great Britain, United Kingdom.</p>